コンピュータ支援創薬の世界市場レポート 2025年

コンピュータ支援創薬の市場規模は今後数年で急成長が見込まれます。2029年には年間平均成長率（CAGR）12.7％で121億9,000万米ドルに成長します。予測期間の成長は、AIとMLの創薬プロセスへの組み込み、個別化医療へのシフト、ビッグデータの利用可能性の増加と開発、CADDのためのクラウドベースのプラットフォームの採用、新規治療薬の開発に起因することができます。予測期間における主な動向としては、さまざまな利害関係者間の連携、エンドツーエンドのソリューションを提供するAI主導型プラットフォームの拡大、創薬、製品イノベーションなどが挙げられます。

がん患者の有病率の増加は、今後数年間のコンピュータ支援創薬市場の成長を促進すると予測されます。がんは、体内の異常細胞の制御不能な増殖と分裂によって特徴づけられるさまざまな疾患を包含します。がん患者数の増加は、ライフスタイルの変化、都市化、環境汚染、タバコやアルコールの摂取、ヘルスケアへのアクセスや意識の格差など、さまざまな要因に起因しています。コンピュータ支援創薬は、特定の遺伝子変異を持つがん細胞を標的とする薬剤の設計を容易にし、より個別化された効果的ながん治療につながります。例えば、2024年5月、米国を拠点とするがん研究とトレーニングに焦点を当てた機関である国立がん研究所（National Cancer Institute）は、2022年に約2,000万人が新たにがんに罹患し、970万人ががんに関連して死亡したと報告しました。この数字は2040年までに大幅に増加し、毎年約2,990万人が新たにがんに罹患し、1,530万人が死亡すると予測されています。その結果、がん患者数の増加がコンピュータ支援創薬市場の拡大を牽引しています。

コンピュータ支援創薬（CADD）市場の主要企業は、人工知能（AI）を創薬に取り入れるなどの革新的なソリューションを進めており、潜在的な医薬品候補の同定、リード化合物の最適化、個別化医療の開発支援の精度、スピード、効率を向上させています。創薬におけるAIは、機械学習やディープラーニングのような技術の使用を含み、高度なアルゴリズムに依存して新薬の発見と開発の精度を加速・向上させる。例えば、ドイツに本社を置く科学技術企業であるメルクKGaAは、2023年12月、創薬と合成を統合するSaaS（Software-as-a-Service）プラットフォームであるAIDDISONTMを発表しました。AIDDISONTMは、ジェネレーティブAI、機械学習、コンピュータ支援薬物設計を組み合わせ、600億以上の化学的標的から化合物を仮想的にスクリーニングし、最適な合成ルートを推奨することで、医薬品開発をスピードアップします。このプラットフォームは、20年にわたる医薬品研究開発データに基づいて構築されており、無毒性や安定性などの特性を持つ医薬品候補化合物を同定します。メルクのSynthiaTM再合成APIを統合することで、AIDDISONTMはまた、創薬の時間とコストを削減することを目標に、より高い効率性と持続可能性のために医薬品製造を最適化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界コンピュータ支援創薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のコンピュータ支援創薬市場：成長率分析
• 世界のコンピュータ支援創薬市場の実績：規模と成長, 2019-2024
• 世界のコンピュータ支援創薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界コンピュータ支援創薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のコンピュータ支援創薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 構造に基づく医薬品設計
• リガンドベースの医薬品設計
• シーケンスベースのアプローチ
• 世界のコンピュータ支援創薬市場治療領域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経学
• 心血管疾患
• 呼吸器疾患
• 糖尿病
• その他の治療領域
• 世界のコンピュータ支援創薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬会社
• バイオテクノロジー企業
• 調査室
• 世界のコンピュータ支援創薬市場構造に基づく医薬品設計のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• X線結晶構造解析
• 核磁気共鳴（NMR）分光法
• 分子ドッキング研究
• バーチャル上映
• 世界のコンピュータ支援創薬市場リガンドベースの医薬品設計のタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量的構造活性相関（QSAR）モデル
• ファーマコフォアモデリング
• リガンド類似性検索
• フラグメントベースの医薬品設計
• 世界のコンピュータ支援創薬市場、シーケンスベースのアプローチの種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• タンパク質構造予測
• ホモロジーモデリング
• 創薬ターゲット同定のためのバイオインフォマティクス
• 創薬のためのゲノムデータ解析

第7章 地域別・国別分析

• 世界のコンピュータ支援創薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のコンピュータ支援創薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• コンピュータ支援創薬市場：競合情勢
• コンピュータ支援創薬市場：企業プロファイル
  • Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roivant Sciences Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Certara Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• XtalPi Inc.
• Dotmatics Limited
• Simulations Plus Inc.
• ChemAxon Ltd.
• Exscientia Ltd.
• Insilico Medicine Inc.
• Collaborative Drug Discovery Inc.
• OpenEye Scientific Software Inc.
• Nimbus Therapeutics LLC
• Atomwise Inc.
• GNS Healthcare Inc.
• BenevolentAI Limited
• EpiVax Inc.
• Numerate Inc.
• Cloud Pharmaceuticals Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• コンピュータ支援創薬市場2029：新たな機会を提供する国
• コンピュータ支援創薬市場2029：新たな機会を提供するセグメント
• コンピュータ支援創薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Computer-aided drug discovery (CADD) is a methodology that uses computational techniques and algorithms to speed up the drug discovery process. It involves leveraging computer software and advanced technologies to identify, design, and optimize potential drug candidates targeting specific biological sites.

The main types of computer-aided drug discovery include structure-based drug design, ligand-based drug design, and sequence-based approaches. Structure-based drug design (SBDD) focuses on designing molecules based on the 3D structure of a biological target, usually a protein, which is obtained through methods such as X-ray crystallography or NMR spectroscopy. These techniques are applied in various therapeutic areas such as oncology, neurology, cardiovascular diseases, respiratory diseases, diabetes, and more, and are utilized by pharmaceutical companies, biotechnology firms, and research laboratories.

The computer-aided drug discovery market research report is one of a series of new reports from The Business Research Company that provides computer-aided drug discovery market statistics, including computer-aided drug discovery industry global market size, regional shares, competitors with a computer-aided drug discovery market share, detailed computer-aided drug discovery market segments, market trends, and opportunities, and any further data you may need to thrive in the computer-aided drug discovery industry. This computer aided drug discovery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The computer-aided drug discovery market size has grown rapidly in recent years. It will grow from $6.69 $ billion in 2024 to $7.56 $ billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to growth in computational power, increasing improvement of molecular modeling, growing demand from the pharmaceutical industry, support from regulatory bodies and collaborations.

The computer-aided drug discovery market size is expected to see rapid growth in the next few years. It will grow to $12.19 $ billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to incorporation of AI and ML into drug discovery processes, shift towards personalized medicine, increasing availability of big data and the development, adoption of cloud-based platforms for CADD, developing novel therapeutics. Major trends in the forecast period include trend towards collaboration between various stakeholders, expansion of AI-driven platforms that offer end-to-end solutions, drug discovery, and product innovations.

The increasing prevalence of cancer cases is projected to drive the growth of the computer-aided drug discovery market in the coming years. Cancer encompasses a range of diseases marked by the uncontrolled growth and division of abnormal cells within the body. The rising number of cancer cases can be attributed to various factors, including lifestyle changes, urbanization, environmental pollution, and the consumption of tobacco and alcohol, as well as disparities in healthcare access and awareness. Computer-aided drug discovery can facilitate the design of drugs that target cancer cells with specific genetic mutations, leading to more personalized and effective cancer treatments. For instance, in May 2024, the National Cancer Institute, a US-based agency focused on cancer research and training, reported nearly 20 million new cancer cases and 9.7 million cancer-related deaths in 2022. These figures are expected to rise significantly by 2040, with projections of approximately 29.9 million new cases and 15.3 million deaths each year. Consequently, the growing prevalence of cancer cases is driving the expansion of the computer-aided drug discovery market.

Leading companies in the computer-aided drug discovery (CADD) market are advancing innovative solutions, such as incorporating artificial intelligence (AI) into drug discovery, to improve the accuracy, speed, and efficiency of identifying potential drug candidates, optimizing lead compounds, and supporting the development of personalized medicine. AI in drug discovery involves the use of technologies like machine learning and deep learning, which rely on advanced algorithms to accelerate and enhance the precision of discovering and developing new drugs. For example, in December 2023, Merck KGaA, a science and technology company based in Germany, launched AIDDISONTM, a software-as-a-service platform that integrates drug discovery and synthesis. AIDDISONTM combines generative AI, machine learning, and computer-aided drug design to speed up drug development by virtually screening compounds from over 60 billion chemical targets and recommending the best synthesis routes. The platform is built on two decades of pharmaceutical R&D data to identify drug-like candidates with properties such as non-toxicity and stability. By integrating Merck's SynthiaTM retrosynthesis API, AIDDISONTM also optimizes drug manufacturing for greater efficiency and sustainability, with the goal of reducing the time and cost of drug discovery.

In January 2022, Schrodinger Inc., a US-based company specializing in computational tools and software for drug discovery, acquired XTAL BioStructures Inc. for $6 million. This acquisition supports Schrodinger's strategy to advance structure-based drug discovery by integrating its computational platform with experimental structural biology methods. XTAL BioStructures, a US-based biotechnology company, provides structural biology services and reagents to support drug discovery programs.

Major companies operating in the computer-aided drug discovery market are Dassault Systemes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrodinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A

North America was the largest region in the computer-aided drug discovery (CADD) market in 2023. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the computer-aided drug discovery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The computer-aided drug discovery market consists of revenues earned by entities by providing molecular modeling, virtual screening, and pharmacophore modeling. The computer-aided drug discovery(CADD) market also includes sales of multi-target drug design and 3D-QSAR. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Computer-Aided Drug Discovery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on computer-aided drug discovery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for computer-aided drug discovery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The computer-aided drug discovery market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Structure Based Drug Design; Ligand-Based Drug Design; Sequence-Based Approaches
• 2) By Therapeutic Area: Oncology; Neurology; Cardiovascular Disease; Respiratory Disease; Diabetes; Other Therapeutic Areas
• 3) By End User: Pharmaceutical Companies; Biotechnology Companies; Research Laboratories
• Subsegments:
• 1) By Structure Based Drug Design: X-ray Crystallography; Nuclear Magnetic Resonance (NMR) Spectroscopy; Molecular Docking Studies; Virtual Screening
• 2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models; Pharmacophore Modeling; Ligand Similarity Searching; Fragment-Based Drug Design
• 3) By Sequence-Based Approaches: Protein Structure Prediction; Homology Modeling; Bioinformatics for Drug Target Identification; Genomic Data Analysis for Drug Discovery
• Companies Mentioned: Dassault Systemes SE; PerkinElmer Inc.; Roivant Sciences Ltd.; Certara Inc.; Schrodinger Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Computer-Aided Drug Discovery Market Characteristics

3. Computer-Aided Drug Discovery Market Trends And Strategies

4. Computer-Aided Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Computer-Aided Drug Discovery Growth Analysis And Strategic Analysis Framework

• 5.1. Global Computer-Aided Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Computer-Aided Drug Discovery Market Growth Rate Analysis
• 5.4. Global Computer-Aided Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Computer-Aided Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Computer-Aided Drug Discovery Total Addressable Market (TAM)

6. Computer-Aided Drug Discovery Market Segmentation

• 6.1. Global Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Structure Based Drug Design
• Ligand-Based Drug Design
• Sequence-Based Approaches
• 6.2. Global Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurology
• Cardiovascular Disease
• Respiratory Disease
• Diabetes
• Other Therapeutic Areas
• 6.3. Global Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Companies
• Research Laboratories
• 6.4. Global Computer-Aided Drug Discovery Market, Sub-Segmentation Of Structure Based Drug Design, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• X-ray Crystallography
• Nuclear Magnetic Resonance (NMR) Spectroscopy
• Molecular Docking Studies
• Virtual Screening
• 6.5. Global Computer-Aided Drug Discovery Market, Sub-Segmentation Of Ligand-Based Drug Design, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative Structure-Activity Relationship (QSAR) Models
• Pharmacophore Modeling
• Ligand Similarity Searching
• Fragment-Based Drug Design
• 6.6. Global Computer-Aided Drug Discovery Market, Sub-Segmentation Of Sequence-Based Approaches, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Protein Structure Prediction
• Homology Modeling
• Bioinformatics for Drug Target Identification
• Genomic Data Analysis for Drug Discovery

7. Computer-Aided Drug Discovery Market Regional And Country Analysis

• 7.1. Global Computer-Aided Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Computer-Aided Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Computer-Aided Drug Discovery Market

• 8.1. Asia-Pacific Computer-Aided Drug Discovery Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Computer-Aided Drug Discovery Market

• 9.1. China Computer-Aided Drug Discovery Market Overview
• 9.2. China Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Computer-Aided Drug Discovery Market

• 10.1. India Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Computer-Aided Drug Discovery Market

• 11.1. Japan Computer-Aided Drug Discovery Market Overview
• 11.2. Japan Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Computer-Aided Drug Discovery Market

• 12.1. Australia Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Computer-Aided Drug Discovery Market

• 13.1. Indonesia Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Computer-Aided Drug Discovery Market

• 14.1. South Korea Computer-Aided Drug Discovery Market Overview
• 14.2. South Korea Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Computer-Aided Drug Discovery Market

• 15.1. Western Europe Computer-Aided Drug Discovery Market Overview
• 15.2. Western Europe Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Computer-Aided Drug Discovery Market

• 16.1. UK Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Computer-Aided Drug Discovery Market

• 17.1. Germany Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Computer-Aided Drug Discovery Market

• 18.1. France Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Computer-Aided Drug Discovery Market

• 19.1. Italy Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Computer-Aided Drug Discovery Market

• 20.1. Spain Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Computer-Aided Drug Discovery Market

• 21.1. Eastern Europe Computer-Aided Drug Discovery Market Overview
• 21.2. Eastern Europe Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Computer-Aided Drug Discovery Market

• 22.1. Russia Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Computer-Aided Drug Discovery Market

• 23.1. North America Computer-Aided Drug Discovery Market Overview
• 23.2. North America Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Computer-Aided Drug Discovery Market

• 24.1. USA Computer-Aided Drug Discovery Market Overview
• 24.2. USA Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Computer-Aided Drug Discovery Market

• 25.1. Canada Computer-Aided Drug Discovery Market Overview
• 25.2. Canada Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Computer-Aided Drug Discovery Market

• 26.1. South America Computer-Aided Drug Discovery Market Overview
• 26.2. South America Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Computer-Aided Drug Discovery Market

• 27.1. Brazil Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Computer-Aided Drug Discovery Market

• 28.1. Middle East Computer-Aided Drug Discovery Market Overview
• 28.2. Middle East Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Computer-Aided Drug Discovery Market

• 29.1. Africa Computer-Aided Drug Discovery Market Overview
• 29.2. Africa Computer-Aided Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Computer-Aided Drug Discovery Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Computer-Aided Drug Discovery Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Computer-Aided Drug Discovery Market Competitive Landscape And Company Profiles

• 30.1. Computer-Aided Drug Discovery Market Competitive Landscape
• 30.2. Computer-Aided Drug Discovery Market Company Profiles
  • 30.2.1. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roivant Sciences Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Certara Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Computer-Aided Drug Discovery Market Other Major And Innovative Companies

• 31.1. XtalPi Inc.
• 31.2. Dotmatics Limited
• 31.3. Simulations Plus Inc.
• 31.4. ChemAxon Ltd.
• 31.5. Exscientia Ltd.
• 31.6. Insilico Medicine Inc.
• 31.7. Collaborative Drug Discovery Inc.
• 31.8. OpenEye Scientific Software Inc.
• 31.9. Nimbus Therapeutics LLC
• 31.10. Atomwise Inc.
• 31.11. GNS Healthcare Inc.
• 31.12. BenevolentAI Limited
• 31.13. EpiVax Inc.
• 31.14. Numerate Inc.
• 31.15. Cloud Pharmaceuticals Inc.

32. Global Computer-Aided Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Computer-Aided Drug Discovery Market

34. Recent Developments In The Computer-Aided Drug Discovery Market

35. Computer-Aided Drug Discovery Market High Potential Countries, Segments and Strategies

• 35.1 Computer-Aided Drug Discovery Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Computer-Aided Drug Discovery Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Computer-Aided Drug Discovery Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer